Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Adagio Medical Holdings (ADGM) EPS (Weighted Average and Diluted) (2023 - 2026)

Adagio Medical Holdings has reported EPS (Weighted Average and Diluted) over the past 4 years, most recently at -$0.31 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 39.22% to -$0.31 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$1.41 through Mar 2026, up 92.22% year-over-year, with the annual reading at -$1.51 for FY2025, 59.19% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.31 for Q1 2026 at Adagio Medical Holdings, down from -$0.09 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $0.02 in Q3 2024 and troughed at -$14.15 in Q3 2023.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$0.58 (2025), against an average of -$4.5.
  • Year-over-year, EPS (Weighted Average and Diluted) soared 100.14% in 2024 and then plummeted 3400.0% in 2025.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$11.33 in 2023, then soared by 100.18% to $0.02 in 2024, then crashed by 550.0% to -$0.09 in 2025, then plummeted by 244.44% to -$0.31 in 2026.
  • Per Business Quant, the three most recent readings for ADGM's EPS (Weighted Average and Diluted) are -$0.31 (Q1 2026), -$0.09 (Q4 2025), and -$0.66 (Q3 2025).